Metabolomics Research and Toxicology Studies

Metabolomics - Toxicology Studies - Pharma Industry Benefits Heavily - RI Technologies' Market Research Update

http://www.einpresswire.com/article/263688407/metabolomics-toxicology-studies-pharma-industry-benefits-heavily-ri-technologies-market-research-update?n=2

In early drug development stages, Metabolomics can reduce several trial-and-error methods for pharmaceutical companies, leading to savings in costs and efforts. Metabolomics report will help Biotechnology & Healthcare Companies and Market Strategists to Identify Market Opportunities and Competition, and Know and Use Market Research for Exploring New Areas. 

For the past few years, the most commonly used methodologies in systems biology for exploring drug discovery have been genomics and proteomics. Now, metabolomics complements these two methods offering scientists a powerful tool that can uncover enormous amounts of information. The main difference between genomics/proteomics and metabolomics is that while the earlier methods studied genes and proteins, metabolomics focuses on metabolites, which are the substrates and end products of enzymatic reactions. Metabolites are compounds of low molecular weight, which determine the unique characteristics (phenotype) of an organism. This facilitates the identification of specific biological conditions, whether they are healthy or diseased.

While work on detecting and quantifying several metabolites has been continuing for decades, it is only now that scientists are able to compile a complete metabolic profile of an organism. Today research in metabolomics is directed at tracing out specific metabolites corresponding with specific disease states to facilitate drug development.

Metabolomics will make a significant impact in -

•    Development of tools and methodology for research
•    Bioinformatics and software to facilitate collection and analysis of data
•    Pharmaceutical organizations involved in drug discovery and development

The report is available at  

http://www.researchimpact.com/life-science/report.php?link=metabolomics

The report gives an insight into Metabolomics Technologies – Combined/Integrated Systems, Hardware Systems for metabolic analytics and Software Systems. The study includes estimates and projections for the total global metabolomics market. Projections and estimates are also illustrated by geographic region including the United States, Europe, Japan, Asia-Pacific, Canada and Rest of World. Business profiles of 28 major companies are discussed in the report. The report serves as a guide to global metabolomics industry, covering more than 400 companies that are engaged in metabolomics R&D and supply of products and services. Major Contract Research Organizations and Universities serving metabolomics industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

About RI Technologies
RI Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.

To order this report, please contact us -

contactus@researchimpact.comAnasuya VemuriRI Technologieswww.researchimpact.com+91 9676994272

Share on  Facebook ·  Twitter ·  LinkedIn ·  Google+

ADME Toxicology Market Research

Global ADME/TOX market is mainly driven by the efforts of pharmaceutical and biotech companies for reducing time and cost of drug discovery. ADME/Tox profiling of a drug candidate plays a key role in reducing clinical trials cost and time of drug launch to the market. ADME/Tox assayseliminate compounds with lack of bioavailability, lower efficacy and toxicity in early stages, in order to save time and costs in expensive later stages of drug discovery.

RI Technologies' latest update on ADME/TOX Technologies
http://www.researchimpact.com/life-science/report.php?link=adme/tox-technologies

The current study is quite useful in choosing the right technology at the right time to conduct ADME/Tox screening of a drug candidate, to save time and money in the process of obtaining regulatory approval. ADME/Tox is a science that needs to be better understood by strategic decision makers. The risks involved and the end use applications should be major areas of research going further. ADME/Tox is considered a major hurdle in drug discovery today. Companies that produce state-of- art tools and focus on complete solutions will be clear winners. Automation is the way to go with emphasis on lower costs. Clearly, animal models cannot be totally overruled owing to the traditional concerns, and also the comfort level involved since they provide the closest biological environment to human systems.

New technologies in ADME/Tox have evolved from diverse scientific disciplines. The toughest challenge is to integrate several successful features and enable pharmaceutical companies to benefit and reap profits in the future. Though some of the concepts in this industry are still in infant stages, the data generated from other relevant sources can be used to close the gaps. Pharmaceutical companies realize the potential of ADME/Tox technologies and are trying more than before to incorporate innovative procedures to reduce drug attrition rates and lessen the burden of costs and save precious time.

Strategic partnerships between pharmaceutical and biotechnology companies are the order of the day, and the trend is increasing globally. Another significant trend is the alliance between Pharma and Biotech companies and information technology companies such as Microsoft, IBM, Oracle, Sun, and Infosys, etc. The computer platforms generated by such companies help managing and analyzing the huge amounts of data produced from ADME/Tox technologies such as High Throughput Screening (HTS) and other computational techniques. Effective R&D strategy involves efficient data management and implementation plans. The new technologies promise improved efficacy, decreased toxicity in patients, and reduced time frames and expenditures.

For more information, please contact us.

contactus@researchimpact.com

+91 9676994272

www.researchimpact.com

DNA SEQUENCING MARKET RESEARCH REPORT - APRIL 2015

RI Technologies' DNA Sequencing Market research report presents an in depth analysis of DNA Sequencing market. The study emphasizes on both, the Methods and Instruments/Software of DNA Sequencing in Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics application areas. 

http://www.researchimpact.com/life-science/report.php?link=dna-sequencing

Automated and Non-Automated (Sanger's, Maxam-Gilbert and Pyrosequencing) DNA Sequencing Methods are analyzed. he major Instruments/Software segments encompass Instruments (DNA Sequencers, DNA Synthesizers, DNA Sequencing Kits, and Microarray Technology) and Bio-Informatics. In depth Application analysis of Medical Research fields such as Proteomics, Pharmacogenomics and Molecular Diagnostics is also covered. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more 500 companies that are engaged in DNA Sequencing services, instrumentation, R&D and supply of products and services. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, Japan and Rest of World. 

DNA is the carrier of genetic information in living organisms. It is said to be the blue print of an organism coordinating the various cellular activities and development. It regulates growth and metabolism and controls the traits, for example eye color. The order or sequence of the bases constitutes the specific instruction for a trait or activity. For example, the sequence ATCGTT may code for blue eye color and ATCGCT may express into brown eye color. But complex traits like intelligence appear to be influenced partly by inheritance and partly by environmental condition. The introduction of DNA sequencing has extensively accelerated the pace of biological research and various discoveries. The quick pace of sequencing can easily be achieved by employing sophisticated modern DNA sequencing technology. This has enabled the large-scale sequencing of the human genome, which is part of the Human Genome Project. The numerous related projects by scientific collaboration have succeeded in generating the complete DNA sequences of for many plants, animals and microbial genomes across the globe. g prominence because it offers a ray of hope for those afflicted with genetic disorders.

For more information on this report, please view

http://www.researchimpact.com/life-science/report.php?link=dna-sequencing

www.researchimpact.com

Biotech Market Research Reports - April 2015 - Updates from RI Technologies

Market research reports need continuous updations to help readers get the latest information. As part of its updation program, RI Technologies has updated its entire portfolio of biotech and healthcare related market research reports. The company's latest press release - 

http://www.pressat.co.uk/releases/biotechnology-and-healthcare-market-research-reports-2nd-quarter-2015-latest-updates-from-ri-technologies-ede850c1972932065a4a47f32e178f30/

RI Technologies updates its reports periodically to stay ahead in the market and provide latest corporate and industry information.

Biotechnology and healthcare related market research studies are available at -

http://www.researchimpact.com/life-science/

For more information you may please contact our help desk at contactus@researchimpact.com
Phone: +91 9676994272
www.researchimpact.com

Biotechnology - an ever growing marketplace

Life sciences is an ever growing marketplace. There have been huge advances in science over the last few decades. Biotechnology has impacted every sector of human life including - food, agriculture, pharma, etc. Biotechnology involves use of living organisms to produce newer products.

Biotechnology has touched our lives - with new vaccines, GM crops, biopesticides, biologics, drug discovery and development, bioimplants, tissue repairs, stem cells research for treating several diseases including cardiology, infertility, stem cells banking, fermentation technologies, biofuels, and a host of other related fields. Several market studies are available that throw light on several emerging biotechnology areas.
Market research is necessary to study the corporate overview and business prospects for bio products.

Biotechnology and healthcare related market research studies are available at -

http://www.researchimpact.com/life-science/

For more information you may please contact our help desk at contactus@researchimpact.com
Phone: +91 9676994272
www.researchimpact.com

Chiral Chemicals Market research report focuses on the different methods and applications of Chiral Chemicals and their impact. Various Chiral Chemical preparation and separation methods include Traditional, Asymmetric, Biological and Other. Pharmaceuticals, Agrochemicals, Flavors/Fragrances are the different chiral chemical applications discussed. The study provides global market analysis for preparation of Chiral Chemicals by Traditional (Diastereomeric Crystallisation, Chromatography & Chiral Pool), Asymmetric (Synthesis & Catalysis) and Biological (Bio-catalysis & Kinetic Resolution). The study includes estimations and predictions for the total global Chiral Chemicals market. Market value for geographic regions including North America, Europe, Asia-Pacific, Japan, and Rest of World is also provided. The industry is analyzed in US Dollars and includes 186 exclusive exhibits. More than 400 companies are covered that are engaged in Chiral Chemical discovery, R&D, testing, and supply of products and services.

http://www.researchimpact.com/life-science/rc.php?link=chiral-chemicals&sis=report-chapter

Biotechnology for Business

Biotechnology market reports observe biotech and medical market trends, survey competition, and provide key market statistics of markets by type, application, and other market parameters. 

The reports typically comprise of market segmentation, market size, demand and supply statistics, sales drivers, market trends, growth forecasts, market shares, product developments, patents, pipelines, major company profiles, technology trends, ongoing and upcoming research, sales channels, distribution analysis, and other key market research. The life science reports are assessed by quality industry experts who conduct several primary and secondary research before putting forth the reports.

 Diligent biotechnology market research reports are the culmination of exhaustive efforts by lead analysts. Industry insiders are consulted, interviewed, and reliable data is built upon. 

The reports typically comprise of market segmentation, market size, demand and supply statistics, sales drivers, market trends, growth forecasts, market shares, product developments, patents, pipelines, major company profiles, technology trends, ongoing and upcoming research, sales channels, distribution analysis, and other key market research. The life science reports are assessed by quality industry experts who conduct several primary and secondary research before putting forth the reports.